Literature DB >> 25784593

Value of a risk scoring tool to predict respiratory syncytial virus disease severity and need for hospitalization in term infants.

Rafat Mosalli1, Asmaa Mostafa Abdul Moez2, Mohammed Janish3, Bosco Paes4.   

Abstract

Several environmental and demographic risk factors have been validated and are used to determine the risk of acquiring severe respiratory syncytial virus (RSV) infection and subsequent hospitalization in late preterm infants born at 33-35 weeks gestational age. The applicability of the same composite model of risk factors in the term population has not been fully explored. The primary objective of this pilot study was to establish whether a risk scoring tool (RST), could predict the severity of RSV infection in term, RSV-positive infants who were hospitalized. A retrospective observational study was conducted in a pediatric unit, over 2 RSV seasons (2011-2013). A convenient sample of 72 children was selected out of a total of 111 RSV-positive cases after exclusions. The RST was applied and a score of respiratory disease severity was determined for each patient. Demographic characteristics were analyzed by standard descriptive methods, χ(2) analysis was utilized for categorical data and ANOVA for comparison between the clinical severity groups and the RST score. A P-value <0.05 was considered significant. Sixty per cent (n = 43) of all infants scored in the low-risk category compared to 26% (n = 19) in the moderate and 14% (n = 10) in the high-risk groups. RST scores were also inconsistent with disease severity. Mean (SD) RST scores for those with mild, moderate, and severe illness were 47.8 [16.4], 41.1 [20.39] and, 41.7 [19.8], respectively (P = 0.17). In conclusion, the RST did not predict accurately the clinical severity of RSV bronchiolitis in term infants nor did it correlate with risk for RSV-related hospitalization.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  respiratory syncytial virus; risk scoring tool; severity; term infants

Mesh:

Year:  2015        PMID: 25784593     DOI: 10.1002/jmv.24189

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

1.  Development of a Global Respiratory Severity Score for Respiratory Syncytial Virus Infection in Infants.

Authors:  Mary T Caserta; Xing Qiu; Brenda Tesini; Lu Wang; Amy Murphy; Anthony Corbett; David J Topham; Ann R Falsey; Jeanne Holden-Wiltse; Edward E Walsh
Journal:  J Infect Dis       Date:  2017-03-01       Impact factor: 5.226

2.  Comparison of Kristjansson Respiratory Score and Wang Respiratory Score in infants with bronchiolitis in a hospital emergency department.

Authors:  Frederico Ramos Pinto; Liane Correia-Costa; Inês Azevedo
Journal:  Hong Kong Physiother J       Date:  2020-08-21

3.  Respiratory syncytial virus associated hospitalizations in preterm infants of 29 to 32 weeks gestational age using a risk score tool for palivizumab prophylaxis.

Authors:  B Resch; V S Bramreiter; S Kurath-Koller; T Freidl; B Urlesberger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-01-11       Impact factor: 3.267

Review 4.  Influenza and other respiratory viruses: standardizing disease severity in surveillance and clinical trials.

Authors:  Barbara Rath; Tim Conrad; Puja Myles; Maren Alchikh; Xiaolin Ma; Christian Hoppe; Franziska Tief; Xi Chen; Patrick Obermeier; Bron Kisler; Brunhilde Schweiger
Journal:  Expert Rev Anti Infect Ther       Date:  2017-05-12       Impact factor: 5.091

5.  Airway gene-expression classifiers for respiratory syncytial virus (RSV) disease severity in infants.

Authors:  Lu Wang; Chin-Yi Chu; Matthew N McCall; Christopher Slaunwhite; Jeanne Holden-Wiltse; Anthony Corbett; Ann R Falsey; David J Topham; Mary T Caserta; Thomas J Mariani; Edward E Walsh; Xing Qiu
Journal:  BMC Med Genomics       Date:  2021-02-25       Impact factor: 3.063

6.  Field testing two existing, standardized respiratory severity scores (LIBSS and ReSViNET) in infants presenting with acute respiratory illness to tertiary hospitals in Rwanda - a validation and inter-rater reliability study.

Authors:  Boniface Hakizimana; Edgar Kalimba; Augustin Ndatinya; Gemma Saint; Clare van Miert; Peter Thomas Cartledge
Journal:  PLoS One       Date:  2021-11-04       Impact factor: 3.240

7.  Machine learning early prediction of respiratory syncytial virus in pediatric hospitalized patients.

Authors:  Chak Foon Tso; Carson Lam; Jacob Calvert; Qingqing Mao
Journal:  Front Pediatr       Date:  2022-08-04       Impact factor: 3.569

8.  Measuring the Severity of Respiratory Illness in the First 2 Years of Life in Preterm and Term Infants.

Authors:  Mary T Caserta; Hongmei Yang; Sanjukta Bandyopadhyay; Xing Qiu; Steven R Gill; James Java; Andrew McDavid; Ann R Falsey; David J Topham; Jeanne Holden-Wiltse; Kristin Scheible; Gloria Pryhuber
Journal:  J Pediatr       Date:  2019-07-31       Impact factor: 4.406

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.